Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R01 NASAL PREPARATIONS
R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01AA Sympathomimetics, plain
R01AA08 Naphazoline
D00743 Naphazoline hydrochloride (JP18/USP)
R01AB Sympathomimetics, combinations excl. corticosteroids
R01AB02 Naphazoline
D00743 Naphazoline hydrochloride (JP18/USP)
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01G DECONGESTANTS AND ANTIALLERGICS
S01GA Sympathomimetics used as decongestants
S01GA01 Naphazoline
D00743 Naphazoline hydrochloride (JP18/USP)
Classification of Japanese OTC drugs [BR:br08313]
Agents for ophthalmologic use
62 General eye drops
D00743 Naphazoline hydrochloride (JP18/USP)
Agents for otolaryngologic use
70 Nasal sprays for inflammation
D00743 Naphazoline hydrochloride (JP18/USP)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Naphazoline
D00743 Naphazoline hydrochloride (JP18/USP)
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01450 alpha-Adrenergic receptor agonist
DG01448 alpha1-Adrenergic receptor agonist
DG01032 Naphazoline
D00743 Naphazoline hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA1
D00743 Naphazoline hydrochloride (JP18/USP)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00743 Naphazoline hydrochloride
Rx-to-OTC switch list in the USA [br08315.html]
D00743